Poland vs United Kingdom of Great Britain and Northern Ireland: Proportion of isolates with decreased susceptibility or resistance
Poland
1.4
in 2018
United Kingdom of Great Britain and Northern Ireland
1.2
in 2018
Poland rank
10th
United Kingdom of Great Britain and Northern Ireland rank
11th
Proportion of isolates with decreased susceptibility or resistance over time
- Poland
- United Kingdom of Great Britain and Northern Ireland
How they compare
Poland currently reports 1.4 against 1.2 in United Kingdom of Great Britain and Northern Ireland, a difference of 0.2.
That makes Poland's figure about 1.2 times United Kingdom of Great Britain and Northern Ireland's.
The two have swapped places 3 times across 8 shared years of data; in 2010 it was United Kingdom of Great Britain and Northern Ireland ahead.
Poland ranks 10th and United Kingdom of Great Britain and Northern Ireland ranks 11th of 27 countries.
United Kingdom of Great Britain and Northern Ireland has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Poland or United Kingdom of Great Britain and Northern Ireland?
- Poland, at 1.4 against 1.2 in United Kingdom of Great Britain and Northern Ireland as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Poland and United Kingdom of Great Britain and Northern Ireland?
- 0.2, with Poland ahead.
- How many years of comparable data are there for Poland and United Kingdom of Great Britain and Northern Ireland?
- 8 years are reported by both, from 2010 to 2018.
- How do Poland and United Kingdom of Great Britain and Northern Ireland rank globally for proportion of isolates with decreased susceptibility or resistance?
- Poland ranks 10th and United Kingdom of Great Britain and Northern Ireland ranks 11th of 27 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.